Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
NCT00004831
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
FED
Sponsor class
Conditions
Erythropoietic Protoporphyria
Interventions
DRUG:
cysteine hydrochloride
Sponsor
FDA Office of Orphan Products Development
Collaborators
[object Object]